Back to top

Chardan Capital Sticks to Their Buy Rating for Ibio (IBIO)

In a report released yesterday, Keay Nakae from Chardan Capital reiterated a Buy rating on Ibio (IBIO – Research Report), with a price target of $5...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

iBio, Inc. (IBIO)